ENOS anticorps (pSer1177)

N° du produit ABIN2626199

Cet anticorps Lapin Polyclonal détecte spécifiquement ENOS dans WB, IF, ICC et IP. Il présente une réactivité envers Humain, Rat, Souris, Porc, Lapin, Chien et Mouton.

Aperçu rapide pour ENOS anticorps (pSer1177) (ABIN2626199)

Antigène: ENOS (NOS3) (Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3))

Reactivité: Humain, Rat, Souris, Porc, Lapin, Chien, Mouton

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ENOS est non-conjugé

Application: Western Blotting (WB), Immunofluorescence (IF), Immunocytochemistry (ICC), Immunoprecipitation (IP)

Détail du produit anti-ENOS anticorps

Épitope: pSer1177

Specificité: Recognizes endogenous levels of eNOS (pS1177) protein.

Purification: Immunoaffinity purified

Immunogène: KLH-conjugated synthetic peptide encompassing a sequence within the C-terminal region of human eNOS.

Type of Immunogen: Synthetic peptide

Information d'application

Indications d'application: Approved: ICC (1:100 - 1:500), IF, IP (1:10 - 1:100), WB (1:500 - 1:1000)

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: PBS,  pH 7.3, 0.01 % sodium azide, 30 % glycerol.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Aliquot to avoid freeze/thaw cycles.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot to avoid freeze/thaw cycles.

Détails sur ENOS

Antigène: ENOS (NOS3) (Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3))

Autre désignation: NOS3 / eNOS

Sujet: Name/Gene ID: NOS3

Synonyms: NOS3, Constitutive NOS, CNOS, Endothelial NOS, ECNOS, NOS type III, NOSIII, EC-NOS, ENOS, Nitric oxide synthase 3

ID gène: 4846

Pathways: ACE Inhibitor Pathway, Regulation of Systemic Arterial Blood Pressure by Hormones, Cellular Response to Molecule of Bacterial Origin, Myometrial Relaxation and Contraction, Signaling Events mediated by VEGFR1 and VEGFR2, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling